Anjan Tibrewala

Medicine & Life Sciences

1. Heart-Assist Devices 100%
2. Takotsubo Cardiomyopathy 69%
3. Heart Failure 32%
4. Mortality 28%
5. Vasa Vasorum 25%
6. Guidelines 23%
7. Systemic Inflammatory Response Syndrome 21%
8. Purinergic P1 Receptors 21%
9. Secondary Prevention 19%
10. Anthracyclines 19%
11. Adventitia 17%
12. Acute Coronary Syndrome 17%
13. Pulmonary Hypertension 16%
14. Adenosine Diphosphate 16%
15. Aortic Valve 16%
16. Surgical Instruments 16%
17. Cardiovascular Diseases 15%
18. Morbidity 15%
19. Stroke 14%
20. Registries 13%
21. Ultrasonography 13%
22. Cholesterol 12%
23. Hemorrhage 11%
24. Lipids 11%
25. Heart 10%
26. Blood Pressure 10%
27. Delivery of Health Care 10%
28. Hydroxymethylglutaryl-CoA Reductase Inhibitors 9%
29. Cardiotoxicity 9%
30. Sternotomy 8%
31. Acute Myeloid Leukemia 8%
32. Cardiology 7%
33. Echocardiography 7%
34. Right Ventricular Function 7%
35. Hospitalization 6%
36. Therapeutics 6%
37. Cardiogenic Shock 6%
38. Chest Tubes 6%
39. Heart Ventricles 6%
40. Diabetes Mellitus 5%
41. Stroke Volume 5%
42. Hyperlipidemias 5%
43. Aortic Valve Stenosis 5%
44. Hypertension 5%
45. Pulmonary Artery 5%